UB Paderborn / Katalog / Suche / in CDI

Clinical pharmacology of bispecific antibody constructs

Journal of clinical pharmacology, 2015-03, Vol.55 (S3), p.S21-S28

2015

Link zum Volltext

Verfügbarkeit prüfen

Correlation of newer indices of dyssynchrony with clinical response in patients undergoing cardiac resynchronisation therapy

Indian heart journal, 2021-03, Vol.73 (2), p.223-227

2021

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma

CPT: pharmacometrics and systems pharmacology, 2021-08, Vol.10 (8), p.851-863

2021

Link zum Volltext

Verfügbarkeit prüfen

How significant is the radiation exposure during electrophysiology study and ablation procedures for supraventricular tachycardia?

Indian heart journal, 2021-03, Vol.73 (2), p.221-222

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method

PloS one, 2016-02, Vol.11 (2), p.e0149225

2016

Link zum Volltext

Verfügbarkeit prüfen

What is the mechanism of paroxysmal atrioventricular block in a patient with recurrent syncope?

Journal of arrhythmia, 2019-12, Vol.35 (6), p.870-872

2019

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal efficacy and safety modeling and simulation framework to aid dose selection of belantamab mafodotin for patients with multiple myeloma

CPT: pharmacometrics and systems pharmacology, 2023-10, Vol.12 (10), p.1411-1424

2023

Link zum Volltext

Verfügbarkeit prüfen

Intermediate term outcome after electrogram guided segmental ostial pulmonary vein isolation using an 8 mm tip catheter for paroxysmal atrial fibrillation

Indian heart journal, 2019-09, Vol.71 (5), p.381-386

2019

Link zum Volltext

Verfügbarkeit prüfen

Esophageal carcinoma: An epidemiological analysis and study of the time trends over the last 20 years from a single center in India

Journal of family medicine and primary care, 2020-03, Vol.9 (3), p.1695-1699

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality

Annals of hepatology, 2017-05, Vol.16 (3), p.442-450

2017

Link zum Volltext

Verfügbarkeit prüfen

Cardiac resynchronization therapy device implantation in a patient with persistent left superior vena cava without communicating innominate vein - should we proceed from the same side? - A dilemma revisited

Indian pacing and electrophysiology journal, 2018-05, Vol.18 (3), p.112-114

2018

Link zum Volltext

Verfügbarkeit prüfen

Where Is the Level of Atrioventricular Block?

Circulation (New York, N.Y.), 2020-10, Vol.142 (17), p.1684-1686

2020

Link zum Volltext

Verfügbarkeit prüfen

Esomeprazole induced galactorrhea: a novel side effect

Clinical journal of gastroenterology, 2016-02, Vol.9 (1), p.13-16

2016

Link zum Volltext

Verfügbarkeit prüfen

Interesting case of spontaneously resolved dysphagia in a young female due to complicated esophageal tuberculosis

Gastroenterology insights, 2017-11, Vol.8 (1)

2017

Link zum Volltext

Verfügbarkeit prüfen

I wonder what the mobile mass is?

The Lancet (British edition), 2011-10, Vol.378 (9802), p.1604-1604

2011

Link zum Volltext

Verfügbarkeit prüfen

Spectrum of chronic small bowel diarrhea with malabsorption in Indian subcontinent: is the trend really changing?

Intestinal research, 2016, 14(1), , pp.75-82

2016

Link zum Volltext

Verfügbarkeit prüfen

A Rare Case of Hypermobile Mesentery With Segmental Small Bowel Pneumatosis Cystoides Intestinalis

Intestinal research, 2015, 13(4), , pp.346-349

2015

Link zum Volltext

Verfügbarkeit prüfen

Pneumothorax leading to pneumopericardium after transvenous lead implantation in a patient with previous epicardial lead

Pacing and clinical electrophysiology, 2021-03, Vol.44 (3), p.545-547

2021

Link zum Volltext

Verfügbarkeit prüfen

Should Race‐Genotype Interactions Be Considered in the Global Development of CYP2C19 Substrates? A Proposed Framework Using Physiologically Based Pharmacokinetic Modeling

Journal of clinical pharmacology, 2017-04, Vol.57 (4), p.417-421

2017

Link zum Volltext

Verfügbarkeit prüfen

Exposure-Response (E-R) for Ocular Safety Endpoints for Belantamab Mafodotin (Belamaf), a B-Cell Maturation Antigen (BCMA)-Targeting Agent, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in the DREAMM-2 Study

Blood, 2020-11, Vol.136 (Supplement 1), p.20-21

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT196: Therapeutic dose selection for belantamab mafodotin, a BCMA-targeting agent, in patients with relapsed/refractory multiple myeloma (RRMM): Application of population pharmacokinetics (PopPK) and exposure-response (E-R) analyses

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT196-CT196

2020

Link zum Volltext

Verfügbarkeit prüfen

A Rare Case of Solitary Peutz Jeghers Type Hamartomatous Duodenal Polyp with Dysplasia

Journal of clinical and diagnostic research, 2016-07, Vol.10 (7), p.OD03-OD04

2016

Link zum Volltext

Verfügbarkeit prüfen

Exposure–Response Analyses for Therapeutic Dose Selection of Belantamab Mafodotin in Patients With Relapsed/Refractory Multiple Myeloma

Clinical pharmacology and therapeutics, 2021-11, Vol.110 (5), p.1282-1292

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors

British journal of cancer, 2023-08, Vol.129 (2), p.309-317

2023

Link zum Volltext

Verfügbarkeit prüfen

Where is the Blood Leaking From?

Journal of clinical and diagnostic research, 2016-08, Vol.10 (8), p.OJ01-OJ02

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Clinical pharmacology of bispecific antibody constructs

Correlation of newer indices of dyssynchrony with clinical response in patients undergoing cardiac resynchronisation therapy

Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma

How significant is the radiation exposure during electrophysiology study and ablation procedures for supraventricular tachycardia?

Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method

What is the mechanism of paroxysmal atrioventricular block in a patient with recurrent syncope?

Longitudinal efficacy and safety modeling and simulation framework to aid dose selection of belantamab mafodotin for patients with multiple myeloma

Intermediate term outcome after electrogram guided segmental ostial pulmonary vein isolation using an 8 mm tip catheter for paroxysmal atrial fibrillation

Esophageal carcinoma: An epidemiological analysis and study of the time trends over the last 20 years from a single center in India

Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality

Cardiac resynchronization therapy device implantation in a patient with persistent left superior vena cava without communicating innominate vein - should we proceed from the same side? - A dilemma revisited

Where Is the Level of Atrioventricular Block?

Esomeprazole induced galactorrhea: a novel side effect

Interesting case of spontaneously resolved dysphagia in a young female due to complicated esophageal tuberculosis

I wonder what the mobile mass is?

Spectrum of chronic small bowel diarrhea with malabsorption in Indian subcontinent: is the trend really changing?

A Rare Case of Hypermobile Mesentery With Segmental Small Bowel Pneumatosis Cystoides Intestinalis

Pneumothorax leading to pneumopericardium after transvenous lead implantation in a patient with previous epicardial lead

Should Race‐Genotype Interactions Be Considered in the Global Development of CYP2C19 Substrates? A Proposed Framework Using Physiologically Based Pharmacokinetic Modeling

Exposure-Response (E-R) for Ocular Safety Endpoints for Belantamab Mafodotin (Belamaf), a B-Cell Maturation Antigen (BCMA)-Targeting Agent, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in the DREAMM-2 Study

Abstract CT196: Therapeutic dose selection for belantamab mafodotin, a BCMA-targeting agent, in patients with relapsed/refractory multiple myeloma (RRMM): Application of population pharmacokinetics (PopPK) and exposure-response (E-R) analyses

A Rare Case of Solitary Peutz Jeghers Type Hamartomatous Duodenal Polyp with Dysplasia

Exposure–Response Analyses for Therapeutic Dose Selection of Belantamab Mafodotin in Patients With Relapsed/Refractory Multiple Myeloma

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors

Where is the Blood Leaking From?

Suchergebnisse filtern